Search hospitals > Iowa > Des Moines
Iowa Methodist Medical Center
Claim this profileDes Moines, Iowa 50309
Global Leader in Skin Cancer
Global Leader in Relapse
Conducts research for Breast Cancer
Conducts research for Stomach Cancer
Conducts research for Lung Cancer
347 reported clinical trials
4 medical researchers
Summary
Iowa Methodist Medical Center is a medical facility located in Des Moines, Iowa. This center is recognized for care of Skin Cancer, Relapse, Breast Cancer, Stomach Cancer, Lung Cancer and other specialties. Iowa Methodist Medical Center is involved with conducting 347 clinical trials across 494 conditions. There are 4 research doctors associated with this hospital, such as Joshua Lukenbill, Samantha L. Mallory, Robert J. Behrens, and Joshua Luckenbill.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Relapse
Global LeaderStage IV
Stage III
Stage I
Top PIs
Joshua LukenbillMedical Oncology and Hematology Associates-Des Moines2 years of reported clinical research
Expert in Skin Cancer
Expert in Cancer
140 reported clinical trials
215 drugs studied
Samantha L. MalloryBlank Children's Hospital7 years of reported clinical research
Expert in Uterine Tumors
Expert in Cancer
56 reported clinical trials
107 drugs studied
Robert J. BehrensIowa Methodist Medical Center4 years of reported clinical research
Expert in Skin Cancer
Studies Breast Cancer
43 reported clinical trials
97 drugs studied
Joshua LuckenbillIowa Methodist Medical Center4 years of reported clinical research
Studies Head and Neck Cancers
1 reported clinical trial
1 drug studied
Clinical Trials running at Iowa Methodist Medical Center
Skin Cancer
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Prostate Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Breast cancer
Stomach Cancer
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Iowa Methodist Medical Center?
Iowa Methodist Medical Center is a medical facility located in Des Moines, Iowa. This center is recognized for care of Skin Cancer, Relapse, Breast Cancer, Stomach Cancer, Lung Cancer and other specialties. Iowa Methodist Medical Center is involved with conducting 347 clinical trials across 494 conditions. There are 4 research doctors associated with this hospital, such as Joshua Lukenbill, Samantha L. Mallory, Robert J. Behrens, and Joshua Luckenbill.
Where is Iowa Methodist Medical Center located?
**Iowa Methodist Medical Center Visitor Information:**
To reach the Iowa Methodist Medical Center in Des Moines, Iowa, exit I-235 at Keo Way south, turn right onto 12th Street, and follow the road up the hill to the campus. Visitor parking is available on both the north and south sides of the campus, as well as in the parking ramp on the west side.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Iowa Methodist Medical Center, part of UnityPoint Health:
- Contact the Central Billing Office at (844) 849-1260 or email FA_CBO_Request@unitypoint.org for policy details and application assistance.
- For insurance matters and payment options, bring your ID, insurance card, and driver's license to admitting/registration, or inquire about the Helping Hand Loan Program.
- If you're facing difficulties paying your bill, reach out to the UnityPoint Health Billing Department at 1-844-849-1260 for support.
What insurance does Iowa Methodist Medical Center accept?
The Iowa Methodist Medical Center, located in Des Moines, Iowa, is part of UnityPoint Health. It has partnerships with various insurance companies, including HealthPartners, Medica, and Wellmark Blue Cross and Blue Shield of Iowa, suggesting these plans may be accepted. For a definitive list of accepted insurance plans, contact the hospital directly or visit their official website.
What awards or recognition has Iowa Methodist Medical Center received?
Iowa Methodist Medical Center has been endowed with $1 million for its Director position, highlighting its commitment to excellence. It is ranked #3 in Iowa and recognized in Central Iowa by U.S. News & World Report. The hospital also features a Virtual Research Data Center (VRDC), showcasing its dedication to advancing medical research.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.